Article Information
History
- November 29, 2022.
Article Versions
- Version 1 (November 29, 2022 - 19:14).
- You are currently viewing Version 2 of this article (November 29, 2022 - 22:33).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- April C. Apostol1,*,
- Kelly S. Otsuka2,*,
- Diego A. López2,*,
- Jasmine Posada3,
- Kirk D.C. Jensen3,4 and
- Anna E. Beaudin5,#
- 1Quantitative and Systems Biology Graduate Program, University of California-Merced, Merced, CA, USA
- 2Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA
- 3Department of Molecular and Cell Biology, University of California, Merced, Merced, CA, USA
- 4Health Science Research Institute, University of California, Merced, Merced, CA, USA
- 5Departments of Internal Medicine and Pathology, and Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
- ↵#Lead Contact/Corresponding Author Correspondence: anna.beaudin{at}hsc.utah.edu
↵* These authors contributed equally
Posted November 29, 2022.
Fetal hematopoietic stem cells are activated during acute prenatal infection with Toxoplasma gondii and IFNγ
